
Debargha Basuli, MD PhD
@DebarghaBasuli
Followers
238
Following
104
Media
1
Statuses
72
Nephrology Asst Professor @ECUHealth_IM I Transplant Nephrology @OHSUNephrology I
Joined November 2021
Confession: I LOVE hyponatremia 🤓 (I know, I know. What can I say, I'm a true internist!) HypoNa is often feared, maligned, and misunderstood - but I promise it doesn't have to be scary! Here are my top 10 hyponatremia tips and tricks - a 🧵
36
532
3K
Fluid overload occurs frequently in critically ill patients with AKI and is one of the indications for continuous kidney replacement therapy (CKRT). In this article, the authors state that available and emerging tools help predict and monitor volume status more actively and
2
54
141
KIDNEYcon Registration is Open! April 6-8, 2024 Little Rock, AR https://t.co/WR0UUcbmUN Little Rock will experience the 2024 Total Solar Eclipse Discount room rates at the DoubleTree Hotel! @NephroRock @nephrosharma @nephrosingh @VelezNephHepato @kidney_boy
kidneycon.org
Registration
2
16
34
Re-reading excellent thread by @NephroMD. In Winzeler paper, UOsm>=500 is highly specific for non-responsiveness but v. insensitive 🤔How about: UOsm>500: don't bother with FR UOsm<300: FR should be first-line approach 300-500: Consider trial of FR ❓
0
6
21
DARE-ESKD 1: Pharmacokinetic Properties of SGLT2 inhibitor (SGLT2i) Dapagliflozin in Patients on Hemodialysis and Peritoneal Dialysis ca. 2023 from @CJASN #Nephpearls - Well tolerated - Slightly dialyzable - Non-accumulating pharmacokinetic properties https://t.co/cTRliEUxPG
2
143
334
Looks like you can #Flozinate your dialysis patients! "In individuals with kidney failure on dialysis, dapagliflozin was well-tolerated, slightly dialyzable, and had non-accumulating pharmacokinetic properties" https://t.co/EUs4jsFEop
9
92
261
✅IT OUT 👇 📢📢📢Tweetorial Alert (1/19)! What is the most common complication of routine outpatient hemodialysis (HD) treatments?
2
32
41
Genomics in Glomerular Disease A GlomCon Pubs summary on genetic diagnoses of glomerular diseases by Dr. Benjamin Tan @NephBen Read more 👉🏻 https://t.co/HCnimnzIdv
#GlomCon
1
12
20
Our article in @NatRevImmunol proposes that nephritis can be classified primarily according to cause, then by the lesion. This would improve management, education, understanding and research. Thanks to @hjanders_hans @PRomagnani and Prof Nelson Leung for a great collaboration.
2
22
60
Sometimes people ask me to share some educational materials. Therefore, my Twitter guide to Gitelman Syndrome! 🫘🧬 The key literature will posted in this 🧵⬇️ 1/11
6
84
230
A nice refresher of high yield kidney disorders! #TBThursday -md https://t.co/cGk9vfze4Q
renalfellow.org
We can expect standardized exams to contain some of the same questions every year. Certain disorders have pathophysiology that seamlessly transitions from basic
0
1
7
Ambulatory Hemodialysis Unit Rounds: Called to see a patient with hypotension: BP 76/40,🧠 OK, CRT 5 seconds 1st step ➡️🛑Ultrafiltration + 300 ml bolus. BP 90/60 Pt is a middle aged ♂️ w ESRD and T2DM 1/9 🧵
18
157
553
📌 A very comprehensive stepwise ECG algorithm 👉 to predict site of origin of idiopathic VAs #ECG #CardioTwitter #EPeeps @adribaran @ECGTalk @DrFerminGarcia @DrJasonAndrade @DhirajGuptaBHRS @SeguraCardio @jvillacastin @smithECGBlog @AskDrShashank @ecgrhythms @iamritu @Hragy
15
271
740
#AKIConsultSeries:👨w T2DM➡️🏥 for fever, dysuria and CVA tenderness. On arrival: ⬇️BP, ⬆️Glucose, ⬆️AGMA. Dx UTI + DKA. Tx: Abx + Insulin Pump + 4 L Crystalloid + NE After resus, pt still oliguric, Cr 3.2. NE 0.7 ug/kg/min,🧠confused, BP 85/62, HR 123, 2L O2. CRT 4 sec 1/12
27
193
586
1) Welcome to this new #accredited #tweetorial on best practices for providing #interprofessional, multidisciplinary, and multimodal pharmacologic therapy for patients with #CKD-associated anemia #aCKD. #MedTwitter #FOAMed #nephtwitter @MedTweetorials
1
19
30
1) Welcome to a new #accredited #tweetorial on the latest advances in the management of #CKD in the setting of patients with and without #T2D--this time with a hot-off-the-presses update from #ASN22 #KIDNEYWEEK2022: eagerly-awaited results of the #EMPA_KIDNEY trial.
2
22
57
KDIGO is pleased to announce the publication of the 2022 Diabetes Management in CKD Guideline. Read the Guideline: https://t.co/A6LdZbr3qg Read the Executive Summary: https://t.co/vnt32SGix3 Read the News Release: https://t.co/LMc8JRFyM2
#diabetes #CKD
6
332
645
🧵Complex #Hemodynamics in ESRD: Middle age pt ➡️ 🏥 for syncope HPI: Low BP during HD sessions. Does not achieve dry weight. Today she has had 6 episodes of syncope! Last episode happened as she stood up from a chair BP 88/62, HR 87 🧠 OK, CRT 2 sec 1/8
16
93
259